IRIS Accounts Production v23.3.0.418 09542833 Board of Directors 1.5.22 30.4.23 30.4.23 false true false false true false A Ordinary 1.00000 B Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure095428332022-04-30095428332023-04-30095428332022-05-012023-04-30095428332021-04-30095428332021-05-012022-04-30095428332022-04-3009542833ns16:EnglandWales2022-05-012023-04-3009542833ns15:PoundSterling2022-05-012023-04-3009542833ns11:Director12022-05-012023-04-3009542833ns11:PrivateLimitedCompanyLtd2022-05-012023-04-3009542833ns11:SmallEntities2022-05-012023-04-3009542833ns11:AuditExempt-NoAccountantsReport2022-05-012023-04-3009542833ns11:SmallCompaniesRegimeForDirectorsReport2022-05-012023-04-3009542833ns11:SmallCompaniesRegimeForAccounts2022-05-012023-04-3009542833ns11:FullAccounts2022-05-012023-04-3009542833ns11:OrdinaryShareClass22022-05-012023-04-3009542833ns11:OrdinaryShareClass32022-05-012023-04-3009542833ns11:Director22022-05-012023-04-3009542833ns11:RegisteredOffice2022-05-012023-04-3009542833ns6:CurrentFinancialInstruments2023-04-3009542833ns6:CurrentFinancialInstruments2022-04-3009542833ns6:ShareCapital2023-04-3009542833ns6:ShareCapital2022-04-3009542833ns6:RetainedEarningsAccumulatedLosses2023-04-3009542833ns6:RetainedEarningsAccumulatedLosses2022-04-3009542833ns6:FurnitureFittings2022-05-012023-04-3009542833ns6:ComputerEquipment2022-05-012023-04-3009542833ns6:FurnitureFittings2022-04-3009542833ns6:ComputerEquipment2022-04-3009542833ns6:FurnitureFittings2023-04-3009542833ns6:ComputerEquipment2023-04-3009542833ns6:FurnitureFittings2022-04-3009542833ns6:ComputerEquipment2022-04-3009542833ns6:AdditionsToInvestments2023-04-3009542833ns6:CostValuation2023-04-3009542833ns6:WithinOneYearns6:CurrentFinancialInstruments2023-04-3009542833ns6:WithinOneYearns6:CurrentFinancialInstruments2022-04-3009542833ns11:OrdinaryShareClass22023-04-3009542833ns11:OrdinaryShareClass32023-04-3009542833ns6:RetainedEarningsAccumulatedLosses2022-04-3009542833ns6:RetainedEarningsAccumulatedLosses2022-05-012023-04-30
REGISTERED NUMBER: 09542833 (England and Wales)














Unaudited Financial Statements

for the Year Ended 30 April 2023

for

AYAN MEDICS LIMITED

AYAN MEDICS LIMITED (REGISTERED NUMBER: 09542833)

Contents of the Financial Statements
for the year ended 30 April 2023










Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 3


AYAN MEDICS LIMITED

Company Information
for the year ended 30 April 2023







Directors: Dr D M Maradia
Mrs A Maradia





Registered office: Juniper House
Warley Hill Business Park
The Drive
Brentwood
Essex
CM13 3BE





Registered number: 09542833 (England and Wales)





Accountants: Haines Watts South East LLP
Chartered Accountants
Juniper House
Warley Hill Business Park
The Drive
Brentwood
Essex
CM13 3BE

AYAN MEDICS LIMITED (REGISTERED NUMBER: 09542833)

Statement of Financial Position
30 April 2023

2023 2022
Notes £    £    £    £   
Fixed assets
Tangible assets 4 10,346 1,917
Investments 5 16,788 -
27,134 1,917

Current assets
Debtors 6 12 222
Cash at bank 112,846 81,452
112,858 81,674
Creditors
Amounts falling due within one year 7 21,543 17,887
Net current assets 91,315 63,787
Total assets less current liabilities 118,449 65,704

Capital and reserves
Called up share capital 8 100 100
Retained earnings 9 118,349 65,604
Shareholders' funds 118,449 65,704

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 16 November 2023 and were signed on its behalf by:





Dr D M Maradia - Director


AYAN MEDICS LIMITED (REGISTERED NUMBER: 09542833)

Notes to the Financial Statements
for the year ended 30 April 2023


1. Statutory information

Ayan Medics Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. Accounting policies

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 20% on reducing balance
Computer equipment - 15% on cost

Financial instruments
Financial assets and financial liabilities are recognised in the balance sheet when the company becomes a party to the contractual provisions of the instrument.

Trade and other debtors and creditors are classified as basic financial instruments and measured at initial recognition at transaction price. Debtors and creditors are subsequently measured at amortised cost using the effective interest rate method. A provision is established when there is objective evidence that the company will not be able to collect all amounts due.

Cash and cash equivalents are classified as basic financial instruments and comprise cash in hand and at bank and bank overdrafts.

Financial liabilities and equity instruments issued by the company are classified in accordance with the substance of the contractual arrangements entered into and the definitions of a financial liability and an equity instrument. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Equity instruments issued by the company are recorded at the proceeds received, net of direct issue costs.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

3. Employees and directors

The average number of employees during the year was 2 (2022 - 2 ) .

AYAN MEDICS LIMITED (REGISTERED NUMBER: 09542833)

Notes to the Financial Statements - continued
for the year ended 30 April 2023


4. Tangible fixed assets
Fixtures
and Computer
fittings equipment Totals
£    £    £   
Cost
At 1 May 2022 - 2,957 2,957
Additions 9,000 819 9,819
At 30 April 2023 9,000 3,776 12,776
Depreciation
At 1 May 2022 - 1,040 1,040
Charge for year 900 490 1,390
At 30 April 2023 900 1,530 2,430
Net book value
At 30 April 2023 8,100 2,246 10,346
At 30 April 2022 - 1,917 1,917

5. Fixed asset investments
Other
investments
£   
Cost
Additions 16,788
At 30 April 2023 16,788
Net book value
At 30 April 2023 16,788

6. Debtors: amounts falling due within one year
2023 2022
£    £   
Other debtors 12 222

7. Creditors: amounts falling due within one year
2023 2022
£    £   
Taxation and social security 19,891 17,023
Other creditors 1,652 864
21,543 17,887

8. Called up share capital

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
51 A Ordinary £1 51 51
49 B Ordinary £1 49 49
100 100

AYAN MEDICS LIMITED (REGISTERED NUMBER: 09542833)

Notes to the Financial Statements - continued
for the year ended 30 April 2023


9. Reserves
Retained
earnings
£   

At 1 May 2022 65,604
Profit for the year 93,745
Dividends (41,000 )
At 30 April 2023 118,349